全文获取类型
收费全文 | 4032篇 |
免费 | 305篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 99篇 |
儿科学 | 138篇 |
妇产科学 | 56篇 |
基础医学 | 703篇 |
口腔科学 | 78篇 |
临床医学 | 340篇 |
内科学 | 781篇 |
皮肤病学 | 64篇 |
神经病学 | 355篇 |
特种医学 | 174篇 |
外科学 | 491篇 |
综合类 | 14篇 |
一般理论 | 2篇 |
预防医学 | 430篇 |
眼科学 | 54篇 |
药学 | 254篇 |
中国医学 | 8篇 |
肿瘤学 | 300篇 |
出版年
2023年 | 28篇 |
2022年 | 39篇 |
2021年 | 76篇 |
2020年 | 63篇 |
2019年 | 77篇 |
2018年 | 100篇 |
2017年 | 86篇 |
2016年 | 92篇 |
2015年 | 122篇 |
2014年 | 132篇 |
2013年 | 177篇 |
2012年 | 266篇 |
2011年 | 260篇 |
2010年 | 161篇 |
2009年 | 168篇 |
2008年 | 250篇 |
2007年 | 274篇 |
2006年 | 219篇 |
2005年 | 264篇 |
2004年 | 220篇 |
2003年 | 216篇 |
2002年 | 207篇 |
2001年 | 55篇 |
2000年 | 55篇 |
1999年 | 58篇 |
1998年 | 51篇 |
1997年 | 42篇 |
1996年 | 35篇 |
1995年 | 38篇 |
1994年 | 29篇 |
1993年 | 23篇 |
1992年 | 23篇 |
1991年 | 25篇 |
1990年 | 28篇 |
1989年 | 17篇 |
1988年 | 13篇 |
1986年 | 16篇 |
1985年 | 18篇 |
1984年 | 14篇 |
1982年 | 16篇 |
1981年 | 20篇 |
1980年 | 22篇 |
1979年 | 15篇 |
1978年 | 16篇 |
1977年 | 13篇 |
1975年 | 17篇 |
1974年 | 20篇 |
1972年 | 19篇 |
1971年 | 12篇 |
1969年 | 16篇 |
排序方式: 共有4341条查询结果,搜索用时 31 毫秒
101.
102.
Kornelia Neveling Ilse Feenstra Christian Gilissen Lies H. Hoefsloot Erik‐Jan Kamsteeg Arjen R. Mensenkamp Richard J. T. Rodenburg Helger G. Yntema Liesbeth Spruijt Sascha Vermeer Tuula Rinne Koen L. van Gassen Danielle Bodmer Dorien Lugtenberg Rick de Reuver Wendy Buijsman Ronny C. Derks Nienke Wieskamp Bert van den Heuvel Marjolijn J.L. Ligtenberg Hannie Kremer David A. Koolen Bart P.C. van de Warrenburg Frans P.M. Cremers Carlo L.M. Marcelis Jan A.M. Smeitink Saskia B. Wortmann Wendy A.G. van Zelst‐Stams Joris A. Veltman Han G. Brunner Hans Scheffer Marcel R. Nelen 《Human mutation》2013,34(12):1721-1726
The advent of massive parallel sequencing is rapidly changing the strategies employed for the genetic diagnosis and research of rare diseases that involve a large number of genes. So far it is not clear whether these approaches perform significantly better than conventional single gene testing as requested by clinicians. The current yield of this traditional diagnostic approach depends on a complex of factors that include gene‐specific phenotype traits, and the relative frequency of the involvement of specific genes. To gauge the impact of the paradigm shift that is occurring in molecular diagnostics, we assessed traditional Sanger‐based sequencing (in 2011) and exome sequencing followed by targeted bioinformatics analysis (in 2012) for five different conditions that are highly heterogeneous, and for which our center provides molecular diagnosis. We find that exome sequencing has a much higher diagnostic yield than Sanger sequencing for deafness, blindness, mitochondrial disease, and movement disorders. For microsatellite‐stable colorectal cancer, this was low under both strategies. Even if all genes that could have been ordered by physicians had been tested, the larger number of genes captured by the exome would still have led to a clearly superior diagnostic yield at a fraction of the cost. 相似文献
103.
Michael L. Nickerson Kate M. Im Kevin J. Misner Wei Tan Hong Lou Bert Gold David W. Wells Hector C. Bravo Karin M. Fredrikson Timothy T. Harkins Patrice Milos Berton Zbar W. Marston Linehan Meredith Yeager Thorkell Andresson Michael Dean G. Steven Bova 《Human mutation》2013,34(9):1231-1241
Metastatic castration‐resistant prostate cancer (mCRPC) is a lethal disease, and molecular markers that differentiate indolent from aggressive subtypes are needed. We sequenced the exomes of five metastatic tumors and healthy kidney tissue from an index case with mCRPC to identify lesions associated with disease progression and metastasis. An Ashkenazi Jewish (AJ) germline founder mutation, del185AG in BRCA1, was observed and AJ ancestry was confirmed. Sixty‐two somatic variants altered proteins in tumors, including cancer‐associated genes, TMPRSS2‐ERG, PBRM1, and TET2. The majority (n = 53) of somatic variants were present in all metastases and only a subset (n = 31) was observed in the primary tumor. Integrating tumor next‐generation sequencing and DNA copy number showed somatic loss of BRCA1 and TMPRSS2‐ERG. We sequenced 19 genes with deleterious mutations in the index case in additional mCRPC samples and detected a frameshift, two somatic missense alterations, tumor loss of heterozygosity, and combinations of germline missense SNPs in TET2. In summary, genetic analysis of metastases from an index case permitted us to infer a chronology for the clonal spread of disease based on sequential accrual of somatic lesions. The role of TET2 in mCRPC deserves additional analysis and may define a subset of metastatic disease. 相似文献
104.
105.
106.
Steinkamp Pieter Jan Voskuil Floris Jan van der Vegt Bert Doff Jan Johannes Schepman Kees-Pieter de Visscher Sebastiaan Antonius Hendrik Johannes Kelder Wendy Jayalakshmi Yalia Gao Jinming Sumer Baran Devrim van Dam Gooitzen Michell Witjes Max Johannes Hendrikus 《Molecular imaging and biology》2021,23(6):809-817
Molecular Imaging and Biology - Intra-operative management of the surgical margin in patients diagnosed with head and neck squamous cell carcinoma (HNSCC) remains challenging as surgeons still have... 相似文献
107.
108.
109.
Lasers in Medical Science - The aim of this study was to assess the effect of two different laser systems on the mineral content of root canal dentin. Thirty-six single canal-extracted mandibular... 相似文献
110.